Recent headlines and conversations for BIIB
"Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer’s Disease at AAIC 2021"
"Biogen Raises Revenue Guidance, Reiterates Earnings Guidance"
Could Biogen Acquire Axsome Therapeutics?
"Rhenman & Partners Asset Management AB Buys Biogen Inc, Veeva Systems Inc, Pfizer Inc, ..."
"EULAV Asset Management Buys Biogen Inc, Splunk Inc, Peloton Interactive Inc, Sells Ansys Inc, ..."
"Warren Buffett, Berkshire sold Biogen stock, grew Kroger stake in Q2"
Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC
Biogen to Present Data from ADUHELM and Alzheimer’s Disease Portfolio at 2021 Alzheimer’s Association International Conference
Biogen Inc. stock outperforms competitors on strong trading day
Why Is Biogen Pursuing a New Direction in Alzheimer's Research?
Biogen and Eisai Announce ADUHELM (aducanumab-avwa) Data Presentations at Alzheimer’s Association International Conference 2021
Mason Hawkins' Southeastern Says Bye to Biogen
Cassava Sciences vs. Biogen
Biogen Inc. stock underperforms Thursday when compared to competitors
"Biogen beats on earnings, says it's brought in $2 million in sales of Alzheimer's drug"
"Ikarian Capital, LLC Buys Biogen Inc, CRISPR Therapeutics AG, Alector Inc, Sells Eli Lilly and ..."
"Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen — How Warren Buffett's Berkshire Adjusted Its Portfolio In Q2"
Biogen Announces Results from Phase 3b NOVA Study Evaluating Every Six-Week Dosing with Natalizumab in Relapsing-Remitting Multiple Sclerosis
"Lombard Odier Asset Management (Switzerland) SA Buys Biogen Inc, Biohaven Pharmaceutical ..."
Biogen (BIIB) Signs New Gene Therapy Deal for CNS Disorders
"Biotech Stock Roundup: AGEN, SRPT Surge & BIIB, REGN Provide Pipeline Updates"
Biogen (BIIB) Eye Disease Drug Misses Primary Goal in Study
"Biogen, Ginkgo Bioworks in Gene-Therapy Manufacturing Platform Collaboration"
Biogen Announces Exercise of Option to Acquire the Investigational Drug TMS-007 for Acute Ischemic Stroke Based on Positive Phase 2a Data
"The Fight Against Alzheimer's Reaches A Moment Of Truth For Biogen, Other Biotech Stocks"
Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform
Biogen Stock And Aducanumab: What This Alzheimer's Treatment Means For Biotech Stocks
"Biogen hires Ginkgo Bioworks for gene therapy manufacturing, to the tune of $120M - Boston Business Journal"
"Great Point Partners Llc Buys Mirati Therapeutics Inc, Biogen Inc, Exelixis Inc, Sells GW ..."
Some Prominent Doctors Continue to Shun Biogen's Alzheimer's Drug
"Southeastern Asset Management Buys Biogen Inc, Alibaba Group Holding, JOYY Inc, Sells DuPont de ..."
"Why Biogen's June 7 Aducanumab PDUFA Date Is A High-Risk, High-Reward Catalyst"
"UPDATE 3-Biogen scraps Alzheimer drug trials, wiping $17 billion off its market value"
"Zacks Industry Outlook Highlights: Regeneron, Gilead Sciences, Amgen, Biogen, BioNTech, Repligen and Ovid Therapeutics"
Biogen: Phase 2/3 Study in X-Linked Retinitis Pigmentosa Didn't Meet Primary Objective
Biogen and Envisagenics Announce Collaboration to Advance RNA Splicing Research
Biogen Announces Topline Results From Phase 2/3 Gene Therapy Study for XLRP
"Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility in Solothurn, Switzerland"
Biogen and Capsigen Announce Collaboration to Discover and Develop Novel AAV Capsids for Targeted CNS and Neuromuscular Disorders
Biogen Provides Regulatory Update on the Supplemental Biologic License Application (sBLA) for Subcutaneous Administration of TYSABRI (natalizumab)
"Palo Alto Investors, LLC Buys eHealth Inc, Biogen Inc, Gritstone Bio Inc, Sells Staar Surgical ..."
"Biogen, Ginkgo Bioworks Collaborate To Develop Gene Therapy Manufacturing Platform"
Biogen Exercises Option to Acquire Investigational Drug TMS-007
"Biogen Inc. stock falls Friday, underperforms market"
"The Zacks Analyst Blog Highlights: Regeneron, Moderna, Minerva Neurosciences, Amgen and Biogen"
"Annovis Bio Stock Doubles As Alzheimer's Drug Tops Biogen, Cassava Sciences"
"ANVS Stock Rockets As Its Alzheimer's Drug Outperforms Biogen, Cassava"
Biogen (BIIB) Decides to Acquire Phase II Stroke Candidate
Biogen teams up with Ginkgo Bioworks to develop gene therapy manufacturing platform
Pressure Mounting On Pharma Company Biogen To Give New Drug In Trials To N.J. Woman With Rare Form Of ALS
